NCT07291154Recruiting
Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy
Source: ClinicalTrials.gov · Last updated 18 Dec 2025
Brief summary (registry, in English)
Many maintenance hemodialysis (MHD) patients develop negative outlooks due to their illnesses and complications, making their quality of life and prognosis a clinical concern. Effective life management and treatment cooperation are crucial to improving dialysis quality and patient outcomes. This trial aims to evaluate whether management through the "Yueya" mini-program and WeChat can provide personalized guidance such as health education, diet, exercise, medication supervision, and condition monitoring to enhance treatment compliance, quality of life, strengthen quality control in the hemodialysis unit, and improve patient prognosis. Patients will be divided into a group receiving support via the "Yueya" mini-program and WeChat, and a control group receiving routine care. Clinical and laboratory indicators, cardiovascular events, death, hospitalization, quality of life, and compliance will be recorded and compared between groups to assess the impact of APP-assisted patient management on the quality of MHD blood purification therapy and the prognosis of MHD patients.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 392 (estimated)
- First submitted
- 18 Sept 2025
- Start date
- 22 Sept 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Yunfeng Xia
- Diseases
- Chronic kidney disease
- NCT number
- NCT07291154
What you commit to
- Study type: Interventional
- Planned participants: 392
- From 22 Sept 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with communication barriers or other conditions that prevent them from cooperating with the study.
- Patients who have a history of acute myocardial infarction, cerebral infarction or intracerebral hemorrhage in the past six months.
- Patients with severe liver cirrhosis, active tuberculosis and AIDS.
Other
- Patients who are not willing to actively cooperate with the study.
Who the study is looking for
- Patients with stage 5 chronic kidney disease, who have received maintenance hemodialysis for more than 3 months, are aged between 18 and 75 years old, and have regular dialysis three times a week.
- Patients with relatively stable condition, who are able to take care of themselves and willing to cooperate with the study.
- Patients who can understand and proficiently use WeChat and the "Yueya" mini - program used in this study.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital of Chongqing Medical University Coordinator of this site? Confirm its status | Chongqing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.